DEUTSCHE BANK AG\ - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 14 filers reported holding ZEALAND PHARMA A S in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q4 2019$15,000
-25.0%
456
-62.0%
0.00%
Q1 2019$20,000
-91.2%
1,200
-91.3%
0.00%
Q3 2018$227,000
+363.3%
13,800
+430.8%
0.00%
Q3 2017$49,0002,6000.00%
Other shareholders
ZEALAND PHARMA A S shareholders Q2 2019
NameSharesValueWeighting ↓
FARALLON CAPITAL MANAGEMENT LLC 750,000$25,875,0000.22%
AWM Investment Company, Inc. 19,981$689,0000.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 5,653$183,0000.08%
OLD MISSION CAPITAL LLC 15,890$548,0000.05%
WELLINGTON MANAGEMENT GROUP LLP 1,433,091$49,442,0000.01%
ROYCE & ASSOCIATES LP 10,000$345,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 44,092$1,521,0000.01%
Rockefeller Capital Management L.P. 8,876$306,0000.00%
Winslow, Evans & Crocker, Inc. 236$10,0000.00%
Filbrandt Wealth Management, LLC 25$1,0000.00%
View complete list of ZEALAND PHARMA A S shareholders